Vaxine is an innovative Australian biotechnology firm based in Adelaide, specializing in the development of vaccines and immunotherapies. The company focuses on creating solutions for infectious diseases like Covid-19 and hepatitis B, and offers therapies for allergies and cancer, contributing significantly to public health advancement.
Vaxine belongs to the Biotechnology, Biotechnology and Life Sciences industry.
What are the specialties of Vaxine?
Vaxine specializes in Vaccine development, Immunotherapy solutions, Covid-19 vaccines, Vaccine adjuvant technology, Artificial intelligence in drug design.
What products and services is Vaxine likely to offer?
Vaxine offers Covid-19 Vaccines, Influenza Vaccines, Hepatitis B Vaccines, Japanese Encephalitis Vaccines, Immunotherapies for Allergy and Cancer.
Who are the competitors of Vaxine?
Competitors of Vaxine are CSL Limited, Vaccinex Inc., Bionomics Limited, Vaxart, Inc., MedImmune (AstraZeneca), Q Biomed Inc..
What does Vaxine do?
Vaxine is an innovative Australian biotechnology firm based in Adelaide, specializing in the development of vaccines and immunotherapies. The company focuses on creating solutions for infectious diseases like Covid-19 and hepatitis B, and offers therapies for allergies and cancer, contributing significantly to public health advancement.